Detalles de la búsqueda
1.
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Dig Dis Sci
; 69(6): 2165-2174, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594435
2.
Endoscopic management of enteral tubes in adult patients - Part 2: Peri- and post-procedural management. European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Endoscopy
; 53(2): 178-195, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33348410
3.
Endoscopic management of enteral tubes in adult patients - Part 1: Definitions and indications. European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Endoscopy
; 53(1): 81-92, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33260229
4.
Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry Study.
J Crohns Colitis
; 17(6): 933-942, 2023 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702552
5.
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(4): 343-355, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736339
6.
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
J Crohns Colitis
; 17(11): 1771-1780, 2023 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310877
7.
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
Trials
; 23(1): 1012, 2022 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36514163
Resultados
1 -
7
de 7
1
Próxima >
>>